Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification

Robert Clarke

doi:10.1158/0008-5472

Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Cancer Research
DOIs	https://doi.org/10.1158/0008-5472
Publication status	Published - 2022

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/0008-5472Licence: CC BY

Cite this

@article{e38665da1cba4b30a2cd53e8ded3c6d2,

title = "Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification",

author = "Robert Clarke",

year = "2022",

doi = "10.1158/0008-5472",

language = "English",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research",

}